製品の概要

  • 製品名Human Munc 13-4 peptide

製品の詳細

  • 由来Synthetic
  • アミノ酸配列
    • 生物種Human
    • 配列C-KQASQHALRPAP
    • 領域1079 to 1090

関連製品

特性

Our Abpromise guarantee covers the use of ab23273 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-Munc 13-4 antibody (ab15723)

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

関連情報

  • 別名
    • FHL 3
    • FHL3
    • FLJ00067
    • HLH 3
    • HLH3
    • HPLH 3
    • HPLH3
    • Jinx
    • Munc13 4
    • Munc13-4
    • Protein unc 13 homolog D
    • Protein unc-13 homolog D
    • UN13D_HUMAN
    • Unc 13 homolog D
    • UNC 13D
    • Unc-13 homolog D (C. elegans)
    • Unc13 homolog D
    • Unc13 homolog D (C elegans)
    • UNC13, C. elegans, homolog of, D
    • UNC13D
    • Unc13h4
    see all
  • 機能Plays a role in cytotoxic granule exocytosis in lymphocytes. Required for both granule maturation and granule docking and priming at the immunologic synapse. Regulates assembly of recycling and late endosomal structures, leading to the formation of an endosomal exocytic compartment that fuses with perforin-containing granules at the immunologic synapse and licences them for exocytosis. Regulates Ca(2+)-dependent secretory lysosome exocytosis in mast cells.
  • 組織特異性Expressed at high levels in spleen, thymus and leukocytes. Also expressed in lung and placenta, and at very low levels in brain, heart, skeletal muscle and kidney. Expressed in cytotoxic T-lymphocytes (CTL) and mast cells.
  • 関連疾患Defects in UNC13D are the cause of hemophagocytic lymphohistiocytosis familial type 3 (FHL3) [MIM:608898]; also known as HPLH3. Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous, rare autosomal recessive disorder. It is characterized by immune dysregulation with hypercytokinemia and defective natural killer cell function. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia, hypofibrinogenemia, and neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits, and ataxia. Hemophagocytosis is a prominent feature of the disease, and a non-malignant infiltration of macrophages and activated T lymphocytes in lymph nodes, spleen, and other organs is also found.
  • 配列類似性Belongs to the unc-13 family.
    Contains 2 C2 domains.
    Contains 1 MHD1 (MUNC13 homology domain 1) domain.
    Contains 1 MHD2 (MUNC13 homology domain 2) domain.
  • ドメインThe MHD1 and MHD2 domains mediate localization on recycling endosomes and lysosome.
  • 細胞内局在Cytoplasm. Membrane. Late endosome. Recycling endosome. Lysosome. Colocalizes with cytotoxic granules at the plasma membrane. Localizes to endosomal exocytic vesicles.
  • Information by UniProt

Human Munc 13-4 peptide (ab23273) 使用論文

ab23273 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab23273.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"